Science Says!
N—72
Welcome to Issue 72 of Science Says! Our weekly newsletter where you’ll learn the latest healthy aging and C15:0 research news that our team of doctors, scientists, and experts are most excited about—without having to go search for it.
Eric and Steph
Co-Founders, Doctors, Nerds
What Dr. Stephanie Venn-Watson, our co-founder and author of The Longevity Nutrient and over 80 peer-reviewed scientific publications, is reading.
Yep, we’re back after a few weeks of relaxing, recovering, and of course – reading lots of science. This week, we provide an update on nonalcoholic fatty liver disease (NAFLD) as a disease not only of the liver, but of our whole bodies. As Byrne et al. described nearly 10 years ago, NAFLD is a multisystem disease, and the heart is getting all kinds of attention these days.
What is NAFLD and what’s up with the term, MAFLD?
As the name suggests, nonalcoholic fatty liver disease (NAFLD) involves excessive fat deposition in the liver not attributed to alcohol consumption. NAFLD can progress to angry, inflamed livers with dying and scarring cells (aka cirrhosis) – this condition is called nonalcoholic steatohepatitis (NASH).
While NAFLD was an unknown disease 40 years ago, Younossi et al. show that 1 in 3 people today have NAFLD, which is rapidly becoming the leading cause of liver cancer and liver transplants globally. Exercise and healthy diets help to manage NAFLD, but there is currently no cure.
In an effort to help doctors and patients better understand a core driver of NAFLD, a new name has been proposed: MAFLD, which stands for Metabolic (dysregulated)-Associated Fatty Liver Disease. As described by Gofton et al., MAFLD acknowledges the co-occurring conditions of:
Okay, enough acronyms. Let’s talk about NAFLD/MAFLD beyond the liver.
Wait, NAFLD/MAFLD goes beyond the liver?
Unfortunately, yes. NAFLD/MAFLD involves imbalanced metabolism, including insulin resistance and type 2 diabetes. While doctors weren’t initially concerned about NAFLD unless a person progressed to NASH, the latest studies show that just having NAFLD meaningfully increases our risk of shorter lives.
In particular, Younossi et al. share that the most common cause of early death among people with NAFLD is heart disease, followed by cancer outside the liver, and then liver disease. These risks are not just among older people. Alarmingly, the same findings were reported by Simon et al. in children and young adults.
What is the connection between NAFLD and heart disease?
As described by Chew et al. in their editorial titled “The heart of NAFLD”, people with NAFLD are 45% more likely to have a heart-related event and have a higher risk of having coronary heart disease and heart failure.
So, what’s the link? Here are a few reasons why NAFLD affects heart health:
This all means that we really (really) need to care about NAFLD, and how to keep our metabolic, liver and heart health as a top priority for 2024 – and beyond.
Role of C15:0 in supporting liver, metabolic and heart health.
A quick and important note: The update below provides the latest C15:0 science. C15:0 supplements are intended to support a healthy physiological state and are not intended to prevent, manage, treat or cure any disease, including liver and heart disease.
As many of you know, we have spent the past 10 years studying NAFLD. This effort all started while helping aging Navy dolphins (TEDx talk here).
Here is what we and others have found to date:
We are currently working with global leaders in NAFLD to pursue the hypothesis that NAFLD and associated dysregulated metabolism are C15:0 nutritional deficiency syndromes. Stay tuned for more updates on this front.
In the meantime, Happy New Year and have a great week, everyone!
An Amazon #1 Best Seller
A groundbreaking, once-in-a-century discovery that changes how we can age for the better.
Dr. Mark Hyman
15x New York Times bestseller
By clicking "Accept" you allow cookies that improve your experience on our site, help us analyze site performance and usage, and enable us to show relevant marketing content. See Privacy Policy